Press Releases
Company News
View Summary Medivation Announces Participation in Upcoming Investor Conferences
Oct 27, 2008
PDF 8.3 KB Add to Briefcase
  20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Oct 22, 2008
PDF 1.4 MB Add to Briefcase
View Summary Medivation Announces Presentation of 24-Week Clinical Data of MDV3100 in Castration-Resistant Prostate Cancer Patients
Oct 22, 2008
PDF 11.9 KB Add to Briefcase
View Summary Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer
Oct 22, 2008
PDF 8.7 KB Add to Briefcase
View Summary Medivation Receives Corporate Achievement Award From Huntington's Disease Society of America
Oct 16, 2008
PDF 10.0 KB Add to Briefcase
View Summary Pfizer and Medivation Enter into Global Agreement to Co-Develop and Market Dimebon for the Treatment of Alzheimer's and Huntington's Diseases
Sep 3, 2008
PDF 13.3 KB Add to Briefcase
View Summary Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
Sep 2, 2008
PDF 7.9 KB Add to Briefcase
View Summary Medivation Announces Participation in Upcoming Conferences
Aug 28, 2008
PDF 8.0 KB Add to Briefcase
View Summary Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
Aug 11, 2008
PDF 18.0 KB Add to Briefcase
View Summary Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
Aug 4, 2008
PDF 8.0 KB Add to Briefcase
View Summary Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
Aug 1, 2008
PDF 7.9 KB Add to Briefcase
  Alzheimer's Association 2008 International Conference on Alzheimer's Disease (ICAD)
Jul 30, 2008
PDF 1.2 MB Add to Briefcase
View Summary MEDIVATION PRESENTS POSITIVE NEW DATA ON DIMEBON'S LONG-TERM EFFICACY AND NOVEL MECHANISM OF ACTION AT THE INTERNATIONAL CONFERENCE ON ALZHEIMER'S DISEASE
Jul 30, 2008
PDF 12.9 KB Add to Briefcase
View Summary Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease
Jul 17, 2008
PDF 13.2 KB Add to Briefcase
View Summary Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease
Jul 7, 2008
PDF 12.8 KB Add to Briefcase
View Summary Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease
Jul 3, 2008
PDF 9.0 KB Add to Briefcase
View Summary Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimer's Disease
Jun 9, 2008
PDF 12.1 KB Add to Briefcase
View Summary Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
Jun 2, 2008
PDF 12.0 KB Add to Briefcase
View Summary Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
May 15, 2008
PDF 10.4 KB Add to Briefcase
View Summary Medivation Announces Participation in Upcoming Conferences
May 13, 2008
PDF 8.1 KB Add to Briefcase
Showing 241-260 of 335 Page: 1 ... 9 10 11 12 13 14 15 16 17  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Top